<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id><journal-id journal-id-type="iso-abbrev">BMC Genomics</journal-id><journal-title-group><journal-title>BMC Genomics</journal-title></journal-title-group><issn pub-type="epub">1471-2164</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5223358</article-id><article-id pub-id-type="publisher-id">3473</article-id><article-id pub-id-type="doi">10.1186/s12864-016-3473-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Maternal BMI as a predictor of methylation of obesity-related genes in saliva samples from preschool-age Hispanic children at-risk for obesity </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Oelsner</surname><given-names>Kathryn Tully</given-names></name><address><email>tullyk@musc.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Yan</given-names></name><address><email>yan.guo@vanderbilt.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>To</surname><given-names>Sophie Bao-Chieu</given-names></name><address><email>sophie.b.to@vanderbilt.edu</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Non</surname><given-names>Amy L.</given-names></name><address><email>alnon@ucsd.edu</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Barkin</surname><given-names>Shari L.</given-names></name><address><phone>615-322-7080</phone><email>shari.barkin@vanderbilt.edu</email></address><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff1"><label>1</label>College of Medicine, Medical University of South Carolina, 96 Jonathan Lucas St, Suite 601, MSC 617, Charleston, SC 29425 USA </aff><aff id="Aff2"><label>2</label>Center for Quantitative Research, School of Medicine, Vanderbilt University, 2220 Pierce Ave, 571 Preston Research Building, Nashville, TN USA </aff><aff id="Aff3"><label>3</label>Department of Biological Sciences, Vanderbilt University, 1210 BSB, 465 21st Ave S, Nashville, TN USA </aff><aff id="Aff4"><label>4</label>Department of Anthropology, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093 USA </aff><aff id="Aff5"><label>5</label>Department of Pediatrics, Vanderbilt University School of Medicine, 2200 Children’s Way, Doctor’s Office Tower 8232, Nashville, TN 37232-9225 USA </aff><aff id="Aff6"><label>6</label>Pediatric Obesity Research, Diabetes Research and Training Center, Vanderbilt University School of Medicine, 2200 Children’s Way, Doctor’s Office Tower 8232, Nashville, TN 37232-9225 USA </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>1</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>9</day><month>1</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>18</volume><elocation-id>57</elocation-id><history><date date-type="received"><day>11</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>26</day><month>12</month><year>2016</year></date></history><permissions><copyright-statement>© The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title><text><SENT sid="1" pm="."><plain>Background </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="2" pm="."><plain>The study of epigenetic processes and mechanisms present a dynamic approach to assess complex individual variation in obesity susceptibility. </plain></SENT>
<SENT sid="3" pm="."><plain>However, few studies have examined epigenetic patterns in preschool-age children at-risk for obesity despite the relevance of this developmental stage to trajectories of weight gain. </plain></SENT>
<SENT sid="4" pm="."><plain>We hypothesized that salivary DNA methylation patterns of key obesogenic genes in Hispanic children would 1) correlate with maternal BMI and 2) allow for identification of pathways associated with children at-risk for obesity. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="5" pm="."><plain>Results </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="6" pm="."><plain>Genome-wide DNA methylation was conducted on 92 saliva samples collected from Hispanic preschool children using the Infinium Illumina HumanMethylation 450 K BeadChip (Illumina, San Diego, CA, USA), which interrogates &gt;484,000 CpG sites associated with ~24,000 genes. </plain></SENT>
<SENT sid="7" pm="."><plain>The analysis was limited to 936 genes that have been associated with obesity in a prior GWAS Study. </plain></SENT>
</text></SecTag></p><p><SecTag type="ABS"><text><SENT sid="8" pm="."><plain>Child DNA methylation at 17 CpG sites was found to be significantly associated with maternal BMI, with increased methylation at 12 CpG sites and decreased methylation at 5 CpG sites. </plain></SENT>
<SENT sid="9" pm="."><plain>Pathway analysis revealed methylation at these sites related to homocysteine and methionine degradation as well as cysteine biosynthesis and circadian rhythm. </plain></SENT>
<SENT sid="10" pm="."><plain>Furthermore, eight of the 17 CpG sites reside in genes (FSTL1, SORCS2, NRF1, DLC1, PPARGC1B, CHN2, NXPH1) that have prior known associations with obesity, diabetes, and the insulin pathway. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="11" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="12" pm="."><plain>Our study confirms that saliva is a practical human tissue to obtain in community settings and in pediatric populations. </plain></SENT>
<SENT sid="13" pm="."><plain>These salivary findings indicate potential epigenetic differences in Hispanic preschool children at risk for pediatric obesity. </plain></SENT>
<SENT sid="14" pm="."><plain>Identifying early biomarkers and understanding pathways that are epigenetically regulated during this critical stage of child development may present an opportunity for prevention or early intervention for addressing childhood obesity. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="15" pm="."><plain>Trial registration </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="16" pm="."><plain>The clinical trial protocol is available at ClinicalTrials.gov (<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT01316653?term=NCT01316653&amp;rank=1">NCT01316653</ext-link>). </plain></SENT>
<SENT sid="17" pm="."><plain>Registered 3 March 2011 </plain></SENT>
</text></SecTag></p></sec></abstract><SecTag type="KEYWORD"><kwd-group xml:lang="en"><title>Keywords</title><kwd>Obesity</kwd><kwd>Hispanic children</kwd><kwd>Epigenetics</kwd><kwd>Methylation</kwd><kwd>Methionine</kwd><kwd>Cysteine biosynthesis</kwd><kwd>Homocysteine</kwd></kwd-group></SecTag><funding-group><award-group><funding-source><institution>National Heart, Lung, and Blood Institute (US)</institution></funding-source><award-id>5U01HL103620</award-id></award-group><award-group><funding-source><institution>National Institute of Diabetes and Digestive and Kidney Diseases (US)</institution></funding-source><award-id>5P30DK092986-03</award-id></award-group><award-group><funding-source><institution>Vanderbilt Institute for Clinical and Translational Research (US)</institution></funding-source><award-id>5UL1TR0045</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><SecTag type="INTRO"><sec id="Sec1"><title><text><SENT sid="18" pm="."><plain>Background </plain></SENT>
</text></title><p><text><SENT sid="19" pm="."><plain>Prevalence of childhood obesity remains a significant public health concern, especially in Hispanic populations who have the higher pediatric obesity rates [1]. </plain></SENT>
<SENT sid="20" pm="."><plain>Despite having increased risk of developing pediatric and adult obesity compared to other ethnic groups [2], Hispanic children are currently underrepresented in public health research. </plain></SENT>
<SENT sid="21" pm="."><plain>This is particularly significant as Hispanics are the most populous and rapidly growing ethnic minority in the United States, meaning this population’s health comorbidities secondary to obesity will increase healthcare costs and rates of morbidity [3, 4]. </plain></SENT>
<SENT sid="22" pm="."><plain>Genetic predisposition, exposure to unhealthy dietary options, and lack of adequate physical activity have all been identified as contributors to pediatric obesity [5]. </plain></SENT>
<SENT sid="23" pm="."><plain>However, recent literature indicates a more nuanced dynamic mechanism associated with later childhood and adult obesity that reflects the interaction between genetics, environment, and developmental stage via epigenetic modifications [6–8]. </plain></SENT>
<SENT sid="24" pm="."><plain>While the study of the epigenome is complex, it has the potential to inform the prevention and treatment of pediatric obesity by enhancing our understanding of timing and the mechanisms by which the genetic code could be susceptible to environmental influences [9, 10]. </plain></SENT>
</text></p><p><text><SENT sid="25" pm="."><plain>Genetic factors are known to affect multiple cellular and metabolic pathways underlying the development of obesity such as: adipogenesis and fat storage, adipocyte accumulation, the hypothalamic-pituitary adrenal (HPA) system stress response affecting cardiovascular and metabolic health, gastrointestinal tract regulatory signals, orexigenic and anorexigenic and satiety mechanisms, and insulin regulation [11, 12]. </plain></SENT>
<SENT sid="26" pm="."><plain>For example, there is evidence that adipocyte growth in number and size is established early, by the age of 2, and is indicative of future weight trajectory [13]. </plain></SENT>
<SENT sid="27" pm="."><plain>Additionally, maternal Body Mass Index (BMI) is correlated with child’s BMI status at age 6 [14] and is a better indicator of child’s BMI trajectory than child birth weight alone [6]. </plain></SENT>
<SENT sid="28" pm="."><plain>Current maternal BMI has been shown to be significantly associated with current child’s BMI more than other maternal socioeconomic factors (including age, marital status, education). </plain></SENT>
<SENT sid="29" pm="."><plain>These and other studies indicate that both current and pre-pregnancy maternal BMI are significantly associated with child’s BMI trajectory [15, 16]. </plain></SENT>
</text></p><p><text><SENT sid="30" pm="."><plain>However, the epigenetic mechanisms affecting potential candidate genes linked to biological processes, such as adipocyte accumulation, are relatively unknown in pediatric populations. </plain></SENT>
<SENT sid="31" pm="."><plain>Epigenetic mechanisms regulate the level of gene transcription, which occurs through multiple processes including DNA methylation [8, 17]. </plain></SENT>
<SENT sid="32" pm="."><plain>Research indicates that methyl groups can bind the genetic code in either a heritably stable or an environmentally-induced transient manner, affecting the child’s trajectory for excessive weight gain relative to height [18, 19]. </plain></SENT>
<SENT sid="33" pm="."><plain>There is some evidence of in utero environmentally-induced methylation associated with exposure to maternal gestational diabetes [20, 21]; maternal inadequate nutrition or insulin resistance that can cause an adaptive response in the child, resulting in epigenetic modifications signaling caloric retention [22–25]. </plain></SENT>
<SENT sid="34" pm="."><plain>In addition, Liu and colleagues reported that maternal pre-pregnancy BMI was associated with alterations in offspring DNA methylation in cord blood at CpG sites annotated to genes related to the development of various complex chronic diseases, such as cardiovascular disease [9]. </plain></SENT>
</text></p><p><text><SENT sid="35" pm="."><plain>While the study by Liu et al. linked maternal weight phenotypes (normal weight; overweight; and obese) to epigenetic patterns in offspring neonatal cord blood samples [9], children between the ages 3–5 have been relatively understudied in the field of epigenetics. </plain></SENT>
<SENT sid="36" pm="."><plain>This is likely due to the convenience of neonatal cord blood at a younger age and the limited feasibility of obtaining blood samples until older ages. </plain></SENT>
<SENT sid="37" pm="."><plain>Yet, this age range is particularly important as it falls closest to the adiposity rebound stage and could play a significant role in a child’s future BMI trajectory [26]. </plain></SENT>
<SENT sid="38" pm="."><plain>Thus, examining the link between current maternal BMI and young children’s DNA methylation patterns, particularly among Hispanic children at high risk for obesity, can fill important gaps in current epigenetic research. </plain></SENT>
</text></p><p><text><SENT sid="39" pm="."><plain>Saliva is a promising yet relatively underutilized source of DNA [27, 28]. </plain></SENT>
<SENT sid="40" pm="."><plain>Previous studies indicate that up to 74% of DNA in saliva comes from white blood cells, although there is high variability in individual samples [29]. </plain></SENT>
<SENT sid="41" pm="."><plain>Additionally, saliva is part of the gastrointestinal tract, and therefore, an important tissue to examine in obesity research [30]. </plain></SENT>
<SENT sid="42" pm="."><plain>Furthermore, using saliva samples rather than blood to yield epigenetic information introduces a more practical method to measure epigenetics from young children in a variety of settings, including the home and community [31]. </plain></SENT>
</text></p><p><text><SENT sid="43" pm="."><plain>While epigenetic patterns are tissue-dependent and results may not be consistent with other tissues [32], this study examines if there is variation in salivary DNA methylation in young children at risk for later obesity. </plain></SENT>
<SENT sid="44" pm="."><plain>We had three study aims: 1) to examine the association of maternal BMI phenotype with methylation patterns in preschool Hispanic child saliva by analyzing CpG sites located in genes previously associated with obesity [33]; 2) to assess if preschool child saliva would yield distinct epigenetic signatures in children at-risk for obesity compared to children of normal weight mothers; and 3) to identify biological pathways and genes in children correlated with maternal BMI. </plain></SENT>
<SENT sid="45" pm="."><plain>These findings could then identify potential epigenetic signatures in saliva among young children at risk for obesity, but not yet obese. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec id="Sec2"><title><text><SENT sid="46" pm="."><plain>Methods </plain></SENT>
</text></title><sec id="Sec3"><title><text><SENT sid="47" pm="."><plain>Ethics statement </plain></SENT>
</text></title><p><text><SENT sid="48" pm="."><plain>The study was approved by the Vanderbilt University Institutional Review Board (IRB No. 120643). </plain></SENT>
<SENT sid="49" pm="."><plain>Data were collected after a parent/legal guardian signed a written informed consent, for themselves and their child, in their preferred language (English or Spanish). </plain></SENT>
<SENT sid="50" pm="."><plain>The clinical trial protocol is available at ClinicalTrials.gov (NCT01316653). </plain></SENT>
<SENT sid="51" pm="."><plain>Registered 3 March 2011. </plain></SENT>
<SENT sid="52" pm="."><plain>The data for this manuscript derive from baseline salivary samples obtained prior to randomization. </plain></SENT>
</text></p></sec><sec id="Sec4"><title><text><SENT sid="53" pm="."><plain>Sample population study subjects </plain></SENT>
</text></title><p><text><SENT sid="54" pm="."><plain>This study involved baseline saliva samples from 92 Hispanic parent-preschool children dyads, who are participating in an ongoing randomized controlled trial (RCT), the Growing Right Onto Wellness (GROW) Trial [34]. </plain></SENT>
<SENT sid="55" pm="."><plain>Children were not necessarily firstborn. </plain></SENT>
<SENT sid="56" pm="."><plain>Eligibility criteria for the RCT included: child 3–5 years old; child’s BMI ≥50 and &lt;95% (at risk for obesity, but not yet obese) [35]; parental commitment to participate in a 3-year randomized controlled trial; parent age ≥18 years; parent and child in good health, without medical conditions necessitating limited physical activity as evaluated by a pre-screen; dyad considered underserved as indicated by the parent self-reporting if they or someone in their household participated in programs such as TennCare (Medicaid), CoverKids, Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), Food Stamps, and/or free and reduced price school meal. </plain></SENT>
<SENT sid="57" pm="."><plain>These children are considered to be at high risk for later childhood and adult obesity [36]. </plain></SENT>
</text></p></sec><sec id="Sec5"><title><text><SENT sid="58" pm="."><plain>Phenotypic data </plain></SENT>
</text></title><p><text><SENT sid="59" pm="."><plain>Height and weight were measured in accordance with standard anthropometric measurement procedures [37, 38]. </plain></SENT>
<SENT sid="60" pm="."><plain>Both values were collected twice, with the mean of the two closest measures used as the final measurement. </plain></SENT>
<SENT sid="61" pm="."><plain>BMI was calculated as weight in kilograms divided by the square of height in meters. </plain></SENT>
<SENT sid="62" pm="."><plain>Table 1 outlines the phenotypic and demographic data for the sample population.Table 1Sample demographicsChild Age, mean (SD)3.78 (0.78)  Age 3, No. </plain></SENT>
<SENT sid="63" pm="."><plain>(%)40 (43)  Age 4, No. </plain></SENT>
<SENT sid="64" pm="."><plain>(%)32 (35)  Age 5, No. </plain></SENT>
<SENT sid="65" pm="."><plain>(%)20 (22)Maternal Age, mean (SD)31.70 (5.75)Gender, No. </plain></SENT>
<SENT sid="66" pm="."><plain>(%)  Female46 (50)  Male46 (50)Maternal BMI (kg/m^2), mean (SD)29.80 (7.60)Maternal Waist Circumference (cm), mean (SD)98.16 (16.04)Child BMI (kg/m^2), mean (SD)16.80 (0.83)Child Waist Circumference (cm), mean (SD)53.34 (3.17)Child and Parent Race, No. </plain></SENT>
<SENT sid="67" pm="."><plain>(%)  Hispanic/Hispanic92 (100) </plain></SENT>
</text></p></sec><sec id="Sec6"><title><text><SENT sid="68" pm="."><plain>Procedures </plain></SENT>
</text></title><p><text><SENT sid="69" pm="."><plain>All salivary samples were collected at baseline in the GROW RCT, before any interventions occurred, using the Oragene DNA saliva kit following a strict protocol [39]. </plain></SENT>
<SENT sid="70" pm="."><plain>All study members wore gloves and immediately capped specimen after collection. </plain></SENT>
<SENT sid="71" pm="."><plain>Samples were sent to the Vanderbilt genetic core for assessment of quality and quantity prior to storage in the Vanderbilt Technologies for Advanced Genomics (VANTAGE) core at Vanderbilt University. </plain></SENT>
<SENT sid="72" pm="."><plain>DNA extraction was performed as per DNA Genotek’s recommendations using the PrepIT L2P reagent. </plain></SENT>
<SENT sid="73" pm="."><plain>Extracted DNA was stored in individually barcoded cryovials at −80° Fahrenheit. </plain></SENT>
<SENT sid="74" pm="."><plain>For children, saliva was obtained using the “baby brush” approach, in which small sponges attached to plastic handles are inserted between cheek and gumline to absorb saliva [40]. </plain></SENT>
<SENT sid="75" pm="."><plain>The phenotypic data derived from a baseline survey and objectively measured anthropomorphic data was collected from participating mother-child pairs. </plain></SENT>
</text></p></sec><sec id="Sec7"><title><text><SENT sid="76" pm="."><plain>Identification of CpG Probes </plain></SENT>
</text></title><p><text><SENT sid="77" pm="."><plain>We focused our analysis on 11,387 CpG sites that resided in 936 genes that have been previously reported in genome-wide association studies (GWAS) to have association with childhood obesity in a Hispanic population [41]. </plain></SENT>
<SENT sid="78" pm="."><plain>Moreover, the original GWAS study’s initial sample size was 815 Hispanic children from 263 families [41]. </plain></SENT>
</text></p></sec><sec id="Sec8"><title><text><SENT sid="79" pm="."><plain>Assay method </plain></SENT>
</text></title><p><text><SENT sid="80" pm="."><plain>Genome-wide DNA methylation was conducted on the 92 saliva samples using the Infinium Illumina HumanMethylation 450 K BeadChip (Illumina, San Diego, CA, USA), which interrogates &gt;484,000 CpG sites associated with ~24,000 genes [42]. </plain></SENT>
<SENT sid="81" pm="."><plain>This microarray spans 99% of genes in the Reference Sequence database, with an average of 17 CpG sites per gene region, and has been previously validated for consistency [43]. </plain></SENT>
<SENT sid="82" pm="."><plain>Arrays were processed using standard protocol [44], with three samples randomly selected to serve as duplicates and one sample run with HapMap DNA to test functionality of reagents. </plain></SENT>
<SENT sid="83" pm="."><plain>Duplicates were measured for high technique consistency with Pearson correlation coefficient (&gt;.99). </plain></SENT>
</text></p></sec><sec id="Sec9"><title><text><SENT sid="84" pm="."><plain>Quality control </plain></SENT>
</text></title><p><text><SENT sid="85" pm="."><plain>Methylation data were quality controlled using Illumina GenomeStudio (V2011.1), Methylation module (V1.9.0). </plain></SENT>
<SENT sid="86" pm="."><plain>The data processing and quality control were performed using the Illumina GenomeStudio, methylation module 1.8. </plain></SENT>
<SENT sid="87" pm="."><plain>The GenomeStudio had built in protocols for conducting methylation array normalization. </plain></SENT>
<SENT sid="88" pm="."><plain>We utilized Background Subtraction, where the background value is derived by averaging the signals of built-in negative control bead types. </plain></SENT>
<SENT sid="89" pm="."><plain>Outliers are removed using the median absolute deviation method. </plain></SENT>
<SENT sid="90" pm="."><plain>Background normalization is capable of minimizing the amount of variation in background signals between arrays. </plain></SENT>
<SENT sid="91" pm="."><plain>This is accomplished using the signals of built-in negative controls, which are designed to be thermodynamically equivalent to the regular probes but lack a specific target in the transcriptome. </plain></SENT>
<SENT sid="92" pm="."><plain>Negative controls allow for estimating the expected signal level in the absence of hybridization to a specific target. </plain></SENT>
<SENT sid="93" pm="."><plain>The average signal of the negative controls is subtracted from the probe signals. </plain></SENT>
<SENT sid="94" pm="."><plain>As a result, the expected signal for unexpressed targets is equal to zero. </plain></SENT>
<SENT sid="95" pm="."><plain>Samples with lower than 98% call rate (i.e. &lt;485,000 probes) were excluded. </plain></SENT>
</text></p><p><text><SENT sid="96" pm="."><plain>Any non-specific cross-reacting probes, probes carrying common SNPs (MAF &gt;1%), or any probes with p-values greater than 0.05 for more than 20% of the sample were sequentially excluded [45, 46]. </plain></SENT>
<SENT sid="97" pm="."><plain>One saliva sample was removed after quality control analysis (total analytic sample of n = 91). </plain></SENT>
<SENT sid="98" pm="."><plain>Normalization at CpG island level was performed using internal control subtracting background noise. </plain></SENT>
</text></p></sec><sec id="Sec10"><title><text><SENT sid="99" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="100" pm="."><plain>We employed an advanced statistical method called elastic net in order to select a reduced set of CpG markers for regression analyses because the number of CpG markers is substantially greater than the number of subjects [47]. </plain></SENT>
<SENT sid="101" pm="."><plain>The elastic net method provides variable selection to produce parsimonious and interpretable models without being severely limited by the sample size [47, 48]. </plain></SENT>
<SENT sid="102" pm="."><plain>While multiple test corrections are not necessary for elastic net [49–51], to demonstrate the more common presentation of results, we report Hochberg adjusted p-values [52]. </plain></SENT>
</text></p><p><text><SENT sid="103" pm="."><plain>The elastic net was performed prior to linear regression analysis to identify CpG sites associated with maternal BMI, due to its clinical relevance to childhood obesity for the Hispanic population [53–55]. </plain></SENT>
<SENT sid="104" pm="."><plain>The CpG sites selected by elastic net were then used in a univariate model to examine the individual association with maternal BMI using a linear regression model where the main outcome was child CpG methylation and the main predictor was maternal BMI, adjusting for covariates that included: child BMI, maternal age, child gender, and child age. </plain></SENT>
</text></p></sec><sec id="Sec11"><title><text><SENT sid="105" pm="."><plain>Pathway analysis </plain></SENT>
</text></title><p><text><SENT sid="106" pm="."><plain>Functional analysis of differentially methylated genes was conducted using Ingenuity Pathway Analysis (IPA) on child CpG Sites determined to be significantly methylated and associated with maternal BMI by linear regression. </plain></SENT>
<SENT sid="107" pm="."><plain>The analysis utilized the Ingenuity Knowledge Base (QIAGEN), a structured collection of five million findings from biomedical literature and integrated third party databases that contains 40,000 nodes with 1,480,000 edges representing cause-effect relationships. </plain></SENT>
<SENT sid="108" pm="."><plain>These cause-and-effect relationships take into account expression, transcription, activation, molecular modification, transport, and binding [56]. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec id="Sec12"><title><text><SENT sid="109" pm="."><plain>Results </plain></SENT>
</text></title><sec id="Sec13"><title><text><SENT sid="110" pm="."><plain>Methylation analysis </plain></SENT>
</text></title><p><text><SENT sid="111" pm="."><plain>The elastic net identified 17 CpG sites that were associated with maternal BMI (Fig. 1). </plain></SENT>
<SENT sid="112" pm="."><plain>Twelve of the 17 CpGs had increased methylation with increased maternal BMI while 5 of the 17 CpGs had decreased methylation associated with increased maternal BMI. </plain></SENT>
<SENT sid="113" pm="."><plain>Of these CpGs, all were significantly and independently associated with maternal BMI, as determined by linear regression (Table 2). </plain></SENT>
<SENT sid="114" pm="."><plain>Five CpGs were found within an enhancer region of the associated gene, 1 CpG was associated with the promotor region, and 5 CpGs were unclassified.Fig. 1Direct Correlation of CpG Site with Maternal Obesity. </plain></SENT>
<SENT sid="115" pm="."><plain>Maternal BMI per Child methylation level for the 17 CpG sites with significant methylation as determined by linear regression. </plain></SENT>
<SENT sid="116" pm="."><plain>Genes indicated in parenthesis; Red line indicating linear regression; dotted line indicating 95% confidence interval Table 2Linear regression analysis of child DNA methylation signal predicted by maternal BMIProbeGeneEffectStandard Deviation P-Value* Associated Pathology cg21790991 a  FSTL1  0.005058  0.001776 0.0156 Obesity [65, 66] Cg03218460  SORCS2  0.003025  0.001091 0.0165 Cardiovascular disease [67] SORCS family associated with Type 1 and 2 Diabetes [67–70]Cg23241637 ZNF804A 0.0024430.000810.0143Schizophrenia [71–75]Cg04798490 SHANK2 0.0023910.0007870.0143Autism [76–81] cg01307483  NRF1  0.002344  0.000879 0.0172 Type 2 Diabetes [82–85]cg19312314 CBS 0.0019520.0008130.0243Cardiovascular Disease [86]Homocystinuria [87–89] cg14321859  DLC1  0.001801  0.00076 0.0243 Insulin-Pathway [90] Hepatocellular Carcinoma [91–94]cg03067613 ATP8B3 0.0015470.0006720.0253Reproduction [95, 96]Liver Disease [97]cg11296553 CEP72 0.0011590.0003120.0041Ulcerative colitis [86]cg16509445 CRYL1 0.0010910.0004270.0204Hepatocellular Carcinoma [98, 99] Cg16344026  PPARGC1B  0.001021  0.000403 0.0204 Obesity [100–102]Cg15354625 ODZ4 0.0009320.0004020.0253Bipolar Disorder [103–105] cg23836542  CHN2  −0.00081  0.000337 0.0243 Insulin-Pathway [106] Type 2 Diabetes [107, 108] cg07511564  NXPH1  −0.00135  0.00061 0.0295 Type 2 Diabetes [109, 110]cg18799510 GRIN3A −0.001710.0006330.0172Schizophrenia [111, 112]Cg14996807 UNC13A −0.001740.000480.0041Amyotrophic lateral sclerosis [113–116] Cg18431297  SORCS2  −0.00316  0.001079 0.0146 Cardiovascular disease [67] SORCS family associated with Type 1 and 2 Diabetes [67–70]*Hochberg adjusted p-values noted aBolded CpG sites are associated with Obesity, Diabetes, and/or the Insulin-Pathway </plain></SENT>
</text></p></sec><sec id="Sec14"><title><text><SENT sid="117" pm="."><plain>Pathway analysis </plain></SENT>
</text></title><p><text><SENT sid="118" pm="."><plain>The top 10 canonical signaling pathways included cysteine biosynthesis, homocysteine degradation, cysteine biosynthesesis III, superpathway of methionine degradation, D-glucuronate degradation I, and Circadium Rhythm Signaling (Table 3).Table 3Top 10 signaling pathways derived from top differentially methylated genesTop Canonical PathwaysAdjusted P-valueCysteine Biosynthesis/Homocysteine Degradation1.55E-03D-glucuronate Degradation I2.33E-03Cysteine Biosynthesis III (Mammalia)1.46E-02Superpathway of Methionine Degradation2.45E-02Circadian Rhythm Signaling2.53E-02Top Diseases and Bio FunctionsDevelopmental Disorders (3 Molecules)4.70E-02 - 7.76E-04 3Hematological Disease (6 Molecules)3.98E-02 - 7.76E-04 6Hereditary Disorder (5 Molecules)4.70E-02 - 7.76E-04 5Metabolic Disease (5 Molecules)3.96E-02 - 7.76E-04 5Neurological Disease (8 Molecules)4.41E-02 - 7.76E-04 </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="Sec15"><title><text><SENT sid="119" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="120" pm="."><plain>To our knowledge, this is the first study examining DNA methylation in saliva samples obtained from preschool-age Hispanic children to investigate epigenetic patterns in children at-risk for later childhood obesity. </plain></SENT>
<SENT sid="121" pm="."><plain>We identified 17 CpG sites in saliva of children to be associated with maternal BMI, indicating a potential intergenerational transmission of risk for obesity in children of obese mothers. </plain></SENT>
</text></p><sec id="Sec16"><title><text><SENT sid="122" pm="."><plain>Effect of maternal BMI phenotype on child DNA methylation in saliva </plain></SENT>
</text></title><p><text><SENT sid="123" pm="."><plain>The 17 CpG probes identified by the Elastic net analysis from saliva samples are consistent with Comuzzie et al’s original GWAS study of whole blood DNA samples from 815 Hispanic children in 263 families [41]. </plain></SENT>
<SENT sid="124" pm="."><plain>The 17 CpG sites in Table 2 were independently and significantly associated with maternal BMI. </plain></SENT>
<SENT sid="125" pm="."><plain>While child age was controlled for in the linear regression analysis, these patterns may change as children age. </plain></SENT>
<SENT sid="126" pm="."><plain>We plan to assess epigenetic signatures and the development of childhood obesity over time in future research. </plain></SENT>
</text></p></sec><sec id="Sec17"><title><text><SENT sid="127" pm="."><plain>Top differentially methylated genes </plain></SENT>
</text></title><p><text><SENT sid="128" pm="."><plain>Eight out of the 17 CpG sites selected by the elastic net analysis reside in genes that are associated with obesity, diabetes, or the insulin pathway by prior studies (Table 2). </plain></SENT>
<SENT sid="129" pm="."><plain>Specifically, the PPARGC1B and NXPH1 genes have been associated with childhood obesity in Brazil and with diabetes in the Mexican-Mestizo populations respectively. </plain></SENT>
<SENT sid="130" pm="."><plain>Since our population was solely Hispanic, we found it interesting that the saliva epigenetic signatures were consistent with known genetic causes of obesity and diabetes in similar populations of Hispanic origins. </plain></SENT>
<SENT sid="131" pm="."><plain>There are similarities between obesogenic and oncogenic states, namely cellular proliferation and inflammation, and it is interesting to note, that in this study two of the genes with significant methylation, DLC1 and CRYL1, are associated with hepatocellular carcinoma. </plain></SENT>
<SENT sid="132" pm="."><plain>These genes have biologic plausibility of contributing to an increased risk of childhood obesity. </plain></SENT>
<SENT sid="133" pm="."><plain>However, because the saliva samples were derived from children within similar non-obese BMI ranges, these significant differences may indicate changes occurring in numerous different pathways even before the clinical presentation of obesity. </plain></SENT>
</text></p><p><text><SENT sid="134" pm="."><plain>One unexpected finding, was that 5 of the 17 CpG sites with significant methylation have strong associations with neurological disease in the literature, specifically schizophrenia, bipolar disorder, autism, and amyotrophic lateral sclerosis (Table 2) [57, 58]. </plain></SENT>
</text></p></sec><sec id="Sec18"><title><text><SENT sid="135" pm="."><plain>Pathway analysis </plain></SENT>
</text></title><p><text><SENT sid="136" pm="."><plain>Pathway analysis identified significant enrichment of genes within pathways involved in conical signaling with respect to methylation in cysteine biosynthesis, homocysteine degradation, cysteine biosynthesis III, and methionine degradation pathways (Table 3). </plain></SENT>
<SENT sid="137" pm="."><plain>These pathways have been associated with obesity previously. </plain></SENT>
<SENT sid="138" pm="."><plain>For example, cysteine biosynthesis has been found to be positively associated with risk of obesity in Hispanic children [59], and total plasma cysteine has been independently associated with obesity and insulin resistance in the same population [60]. </plain></SENT>
<SENT sid="139" pm="."><plain>Furthermore, homocysteine degradation has been found to be positively associated with morbidly obese patients [61], and restriction of methionine intake has been shown to have a significant increase in fat oxidation [62]. </plain></SENT>
<SENT sid="140" pm="."><plain>Circadian rhythm was also identified as a top canonical pathway. </plain></SENT>
<SENT sid="141" pm="."><plain>Circadian rhythms regulate many biological processes and cellular metabolic pathways. </plain></SENT>
<SENT sid="142" pm="."><plain>Disruption of circadian rhythm has an adverse effect on metabolic function [63]. </plain></SENT>
</text></p></sec><sec id="Sec19"><title><text><SENT sid="143" pm="."><plain>Salivary vs blood assays </plain></SENT>
</text></title><p><text><SENT sid="144" pm="."><plain>Comuzzie et al. used DNA samples from whole blood in a GWAS study to identify novel genetic loci associated with the pathophysiology of childhood obesity in Hispanic children ages 4–19 years old [41]. </plain></SENT>
<SENT sid="145" pm="."><plain>Using these same genes in our analyses of saliva, we identified 17 CpG sites in a Hispanic pediatric population with significant methylation and associated with maternal obesogenic phenotypes. </plain></SENT>
<SENT sid="146" pm="."><plain>Thus, this proof of principle study demonstrated that saliva is a probable viable medium for epigenetic testing, which in this case, was consistent to whole blood findings, but we acknowledge that further testing would have to include both blood and saliva samples from the same Hispanic pediatric population to holistically assess the similarities between these 2 tissue samples. </plain></SENT>
<SENT sid="147" pm="."><plain>Previous studies that have investigated both of these tissues in other patient populations indicate that saliva and whole blood findings are consistent, so we would anticipate further investigations to yield similar findings [25, 26]. </plain></SENT>
</text></p></sec><sec id="Sec20"><title><text><SENT sid="148" pm="."><plain>Limitations </plain></SENT>
</text></title><p><text><SENT sid="149" pm="."><plain>Although prior literature indicates that DNA methylation levels in saliva are similar to those in peripheral blood, skin fibroblasts, and buccal swab DNA, it may not reflect the epigenome of adipose tissue, muscle, pancreas, GI system, and pituitary [64], which are implicated in the development of obesity. </plain></SENT>
<SENT sid="150" pm="."><plain>Furthermore, we acknowledge that we cannot assess whether these findings would be consistent in blood samples in this specific population, although prior literature seems to indicate that we would find similar epigenetic methylation patterns if tested. </plain></SENT>
<SENT sid="151" pm="."><plain>We did not correlate gene expression data with methylation changes, and thus can only speculate on the implications for a child’s BMI trajectory. </plain></SENT>
<SENT sid="152" pm="."><plain>P-adjusted values were less likely to be significant due to the large number of genes analyzed in the Illumina Human Methylation Bead Chip 450 K, making our statistically significant findings important, but likely under-identifying other potential statistically significant differential methylation patterns. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="CONCL"><sec id="Sec21"><title><text><SENT sid="153" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><text><SENT sid="154" pm="."><plain>Results of this proof of principle study indicate that saliva is a practical way to obtain biologically plausible findings in an epigenetic analysis of preschool-age children. </plain></SENT>
<SENT sid="155" pm="."><plain>It is important to understand the potential pathways that could be epigenetically regulated in preschool aged children who are not currently obese but at higher risk of obesity. </plain></SENT>
<SENT sid="156" pm="."><plain>Moreover, saliva, an easily accessible tissue, could assist in the future identification of early biomarkers of later childhood obesity and metabolic dysfunction, presenting an opportunity for prevention or early intervention for addressing childhood obesity. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ABBR"><glossary><title>Abbreviations</title><def-list><def-item><term>BMI</term><def><p>Body Mass Index</p></def></def-item><def-item><term>GROW</term><def><p>The Growing Right Onto Wellness Trial</p></def></def-item><def-item><term>GWAS</term><def><p>Genome-wide Association Studies</p></def></def-item><def-item><term>HPA</term><def><p>Hypothalamic-Pituitary Adrenal</p></def></def-item><def-item><term>RCT</term><def><p>Randomized Controlled Trial</p></def></def-item><def-item><term>VANTAGE</term><def><p>the Vanderbilt Technologies for Advanced Genomics</p></def></def-item><def-item><term>WIC</term><def><p>The Special Supplemental Nutrition Program for Women, Infants, and Children</p></def></def-item></def-list></glossary></SecTag><SecTag type="AUTH_CONT"><ack><title>Acknowledgements</title><p>We are grateful for the participation of the Hispanic families involved in this study.</p><sec id="FPar1"><title>Funding</title><p>This research was supported by grants (U01 HL103620) with additional support for the remaining members of the COPTR Consortium (U01HL103622, U01HL103561, U01HD068890, U01HL103629) from the National Heart, Lung, and Blood Institute and the <italic>Eunice Kennedy Shriver</italic> National Institute of Child Health and Development and the Office of Behavioral and Social Sciences Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, And Blood Institute, the National Institutes of Health, or the National Institute of Child Health and Development. This research was also supported by grants 5P30DK092986-03 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and 5UL1TR0045 from the Vanderbilt Institute for Clinical and Translational Research (VICTR).</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p>The datasets supporting the conclusions of this article are available in NCBI’s Gene Expression Omnibus and are accessible through GEO Series access number GSE72556 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72556">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72556</ext-link>).</p></sec><sec id="FPar3"><title>Authors’ contribution</title><p>Conceived and designed the experiments: SB and KT. Analyzed the data: YG. Wrote the paper: SB, KT, AN, ST. Edited and proofed the paper: all authors. All authors read and approved the final manuascript.</p></sec><sec id="FPar4"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="FPar5"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar6"><title>Ethics approval and consent to participate</title><p>Data were collected after informed consent was obtained by parent/legal guardian. This study was approved by the Vanderbilt University Institutional Review Board (IRB No. 120643).</p></sec></ack></SecTag><SecTag type="REF"><ref-list id="Bib1"><title>References</title><ref id="CR1"><text><SENT sid="157" pm="."><plain>1.OgdenCLCarrollMDKitBKFlegalKMPrevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010JAMA201230748349010.1001/jama.2012.40<?supplied-pmid 22253364?>22253364 </plain></SENT>
</text></ref><ref id="CR2"><text><SENT sid="158" pm="."><plain>2.OgdenCLCarrollMDKitBKFlegalKMPrevalence of childhood and adult obesity in the United States, 2011–2012JAMA201431180681410.1001/jama.2014.732<?supplied-pmid 24570244?>24570244 </plain></SENT>
</text></ref><ref id="CR3"><text><SENT sid="159" pm="."><plain>3.RamirezAGallionKDespresCBrennanVMKumanyikaSKZambranaRELatino Childhood ObesityObesity Interventions in Underserved Communities: Evidence and Directions2014BaltimoreThe Johns Hopkins University Press4362 </plain></SENT>
</text></ref><ref id="CR4"><text><SENT sid="160" pm="."><plain>4.Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. </plain></SENT>
<SENT sid="161" pm="."><plain>Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. </plain></SENT>
<SENT sid="162" pm="."><plain>JAMA. </plain></SENT>
<SENT sid="163" pm="."><plain>2004;291(23):2847–50. doi:10.1001/jama.291.23.2847. </plain></SENT>
</text></ref><ref id="CR5"><text><SENT sid="164" pm="."><plain>5.MayALPanLSherryBBlanckHMGaluskaDDaleniusKPolhamusBKettel-KhanLGrummer-StrawnLMVital signs: obesity among low-income, preschool-aged children--United States, 2008–2011MMWR Morb Mortal Wkly Rep20136262963423925173 </plain></SENT>
</text></ref><ref id="CR6"><text><SENT sid="165" pm="."><plain>6.ParsonsTJPowerCManorOFetal and early life growth and body mass index from birth to early adulthood in 1958 British cohort: longitudinal studyBMJ20013231331133510.1136/bmj.323.7325.1331<?supplied-pmid 11739217?>11739217 </plain></SENT>
</text></ref><ref id="CR7"><text><SENT sid="166" pm="."><plain>7.GrissomNMReyesTMGestational overgrowth and undergrowth affect neurodevelopment: similarities and differences from behavior to epigeneticsInt J Dev Neurosci2013314061410.1016/j.ijdevneu.2012.11.006<?supplied-pmid 23201144?>23201144 </plain></SENT>
</text></ref><ref id="CR8"><text><SENT sid="167" pm="."><plain>8.MillerGEChenEParkerKJPsychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanismsPsychol Bull201113795999710.1037/a0024768<?supplied-pmid 21787044?>21787044 </plain></SENT>
</text></ref><ref id="CR9"><text><SENT sid="168" pm="."><plain>9.LiuXChenQTsaiHJWangGHongXZhouYMaternal preconception body mass index and offspring cord blood DNA methylation: exploration of early life origins of diseaseEnviron Mol Mutagen20145522323010.1002/em.21827<?supplied-pmid 24243566?>24243566 </plain></SENT>
</text></ref><ref id="CR10"><text><SENT sid="169" pm="."><plain>10.DuboisLOhm KyvikKGirardMTatone-TokudaFPerusseDHjelmborgJGenetic and environmental contributions to weight, height, and BMI from birth to 19 years of age: an international study of over 12,000 twin pairsPLoS One20127e3015310.1371/journal.pone.0030153<?supplied-pmid 22347368?>22347368 </plain></SENT>
</text></ref><ref id="CR11"><text><SENT sid="170" pm="."><plain>11.BretonCThe hypothalamus-adipose axis is a key target of developmental programming by maternal nutritional manipulationJ Endocrinol2013216R193110.1530/JOE-12-0157<?supplied-pmid 23108716?>23108716 </plain></SENT>
</text></ref><ref id="CR12"><text><SENT sid="171" pm="."><plain>12.BouchardLRabasa-LhoretRFarajMLavoieMEMillJPerusseLDifferential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restrictionAm J Clin Nutr20109130932010.3945/ajcn.2009.28085<?supplied-pmid 19939982?>19939982 </plain></SENT>
</text></ref><ref id="CR13"><text><SENT sid="172" pm="."><plain>13.KnittleJLTimmersKGinsberg-FellnerFBrownREKatzDPThe growth of adipose tissue in children and adolescents. </plain></SENT>
<SENT sid="173" pm="."><plain>Cross-sectional and longitudinal studies of adipose cell number and sizeJ Clin Invest19796323924610.1172/JCI109295<?supplied-pmid 429551?>429551 </plain></SENT>
</text></ref><ref id="CR14"><text><SENT sid="174" pm="."><plain>14.BruneBCGerlachMKSeewaldMJBruneTGEarly postnatal BMI adaptation is regulated during a fixed time period and mainly depends on maternal BMIObesity (Silver Spring)20101879880210.1038/oby.2009.34219834468 </plain></SENT>
</text></ref><ref id="CR15"><text><SENT sid="175" pm="."><plain>15.BarrosoCSRoncancioAHinojosaMBReifsniderEThe association between early childhood overweight and maternal factorsChild Obes2012844945410.1089/chi.2011.0094<?supplied-pmid 23181894?>23181894 </plain></SENT>
</text></ref><ref id="CR16"><text><SENT sid="176" pm="."><plain>16.MamunAAO'CallaghanMJWilliamsGMNajmanJMChange in maternal body mass index is associated with offspring body mass index: a 21-year prospective studyEur J Nutr2013521597160610.1007/s00394-012-0465-7<?supplied-pmid 23197072?>23197072 </plain></SENT>
</text></ref><ref id="CR17"><text><SENT sid="177" pm="."><plain>17.FeinbergAPEpigenetics at the epicenter of modern medicineJAMA200829913455010.1001/jama.299.11.1345<?supplied-pmid 18349095?>18349095 </plain></SENT>
</text></ref><ref id="CR18"><text><SENT sid="178" pm="."><plain>18.FragaMFBallestarEPazMFRoperoSSetienFBallestarMLEpigenetic differences arise during the lifetime of monozygotic twinsProc Natl Acad Sci U S A2005102106041060910.1073/pnas.0500398102<?supplied-pmid 16009939?>16009939 </plain></SENT>
</text></ref><ref id="CR19"><text><SENT sid="179" pm="."><plain>19.HerreraBMKeildsonSLindgrenCMGenetics and epigenetics of obesityMaturitas201169414910.1016/j.maturitas.2011.02.018<?supplied-pmid 21466928?>21466928 </plain></SENT>
</text></ref><ref id="CR20"><text><SENT sid="180" pm="."><plain>20.HillierTAPedulaKLSchmidtMMMullenJACharlesMAPettittDJChildhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemiaDiabetes Care2007302287229210.2337/dc06-2361<?supplied-pmid 17519427?>17519427 </plain></SENT>
</text></ref><ref id="CR21"><text><SENT sid="181" pm="."><plain>21.OrnoyAGrowth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetesPediatr Endocrinol Rev20053104113<?supplied-pmid 16361984?>16361984 </plain></SENT>
</text></ref><ref id="CR22"><text><SENT sid="182" pm="."><plain>22.GodfreyKMSheppardAGluckmanPDLillycropKABurdgeGCMcLeanCEpigenetic gene promoter methylation at birth is associated with child's later adiposityDiabetes2011601528153410.2337/db10-0979<?supplied-pmid 21471513?>21471513 </plain></SENT>
</text></ref><ref id="CR23"><text><SENT sid="183" pm="."><plain>23.HeijmansBTTobiEWSteinADPutterHBlauwGJSusserESPersistent epigenetic differences associated with prenatal exposure to famine in humansProc Natl Acad Sci U S A2008105170461704910.1073/pnas.0806560105<?supplied-pmid 18955703?>18955703 </plain></SENT>
</text></ref><ref id="CR24"><text><SENT sid="184" pm="."><plain>24.HochbergZFeilRConstanciaMFragaMJunienCCarelJCChild health, developmental plasticity, and epigenetic programmingEndocr Rev20113215922410.1210/er.2009-0039<?supplied-pmid 20971919?>20971919 </plain></SENT>
</text></ref><ref id="CR25"><text><SENT sid="185" pm="."><plain>25.SorensenHTSabroeSRothmanKJGillmanMFischerPSorensenTIRelation between weight and length at birth and body mass index in young adulthood: cohort studyBMJ1997315113710.1136/bmj.315.7116.1137<?supplied-pmid 9374888?>9374888 </plain></SENT>
</text></ref><ref id="CR26"><text><SENT sid="186" pm="."><plain>26.WhitakerRCPepeMSWrightJASeidelKDDietzWHEarly adiposity rebound and the risk of adult obesityPediatrics1998101E510.1542/peds.101.3.e5<?supplied-pmid 9481024?>9481024 </plain></SENT>
</text></ref><ref id="CR27"><text><SENT sid="187" pm="."><plain>27.ThompsonTMSharfiDLeeMYrigollenCMNaumovaOYGrigorenkoELComparison of whole-genome DNA methylation patterns in whole blood, saliva, and lymphoblastoid cell linesBehav Genet20134316817610.1007/s10519-012-9579-1<?supplied-pmid 23269419?>23269419 </plain></SENT>
</text></ref><ref id="CR28"><text><SENT sid="188" pm="."><plain>28.AbrahamJEMaranianMJSpiteriIRussellRIngleSLuccariniCSaliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotypingBMC Med Genomics201251910.1186/1755-8794-5-19<?supplied-pmid 22647440?>22647440 </plain></SENT>
</text></ref><ref id="CR29"><text><SENT sid="189" pm="."><plain>29.ThiedeCPrange-KrexGFreiberg-RichterJBornhauserMEhningerGBuccal swabs but not mouthwash samples can be used to obtain pretransplant DNA fingerprints from recipients of allogeneic bone marrow transplantsBone Marrow Transplant20002557557710.1038/sj.bmt.1702170<?supplied-pmid 10713640?>10713640 </plain></SENT>
</text></ref><ref id="CR30"><text><SENT sid="190" pm="."><plain>30.SegataNHaakeSKMannonPLemonKPWaldronLGeversDComposition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samplesGenome Biol201213R4210.1186/gb-2012-13-6-r42<?supplied-pmid 22698087?>22698087 </plain></SENT>
</text></ref><ref id="CR31"><text><SENT sid="191" pm="."><plain>31.WuHCWangQChungWKAndrulisILDalyMBJohnEMCorrelation of DNA methylation levels in blood and saliva DNA in young girls of the LEGACY Girls studyEpigenetics2014992993310.4161/epi.28902<?supplied-pmid 24756002?>24756002 </plain></SENT>
</text></ref><ref id="CR32"><text><SENT sid="192" pm="."><plain>32.WangDLiuXZhouYXieHHongXTsaiHJIndividual variation and longitudinal pattern of genome-wide DNA methylation from birth to the first two years of lifeEpigenetics2012759460510.4161/epi.20117<?supplied-pmid 22522910?>22522910 </plain></SENT>
</text></ref><ref id="CR33"><text><SENT sid="193" pm="."><plain>33.Hindorff LA MJ, Morales J, Junkins HA, Hall PN, Klemm AK, and Manolio TA. </plain></SENT>
<SENT sid="194" pm="."><plain>A Catalog of Published Genome-Wide Association Studies. </plain></SENT>
<SENT sid="195" pm="."><plain>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.genome.gov/gwastudies">www.genome.gov/gwastudies</ext-link>. </plain></SENT>
<SENT sid="196" pm="."><plain>Accessed 6 Dec 2015. </plain></SENT>
</text></ref><ref id="CR34"><text><SENT sid="197" pm="."><plain>34.Po’eEKHeermanWJMistryRSBarkinSLGrowing Right Onto Wellness (GROW): a family-centered, community-based obesity prevention randomized controlled trial for preschool child–parent pairsContemp Clin Trials20133643644910.1016/j.cct.2013.08.013<?supplied-pmid 24012890?>24012890 </plain></SENT>
</text></ref><ref id="CR35"><text><SENT sid="198" pm="."><plain>35.National Center for Health Statistics and the National Center for Chronic Disease Prevention and Health Promotion. </plain></SENT>
<SENT sid="199" pm="."><plain>2000 CDC Growth Charts for the United States: Methods and Development. </plain></SENT>
<SENT sid="200" pm="."><plain>2002;11:246. </plain></SENT>
</text></ref><ref id="CR36"><text><SENT sid="201" pm="."><plain>36.PryorLETremblayREBoivinMTouchetteEDuboisLGenoliniCDevelopmental trajectories of body mass index in early childhood and their risk factors: an 8-year longitudinal studyArch Pediatr Adolesc Med201116590691210.1001/archpediatrics.2011.153<?supplied-pmid 21969392?>21969392 </plain></SENT>
</text></ref><ref id="CR37"><text><SENT sid="202" pm="."><plain>37.BarkinSLGesellSBPo’eEKEscarfullerJTempestiTCulturally Tailored, Family-Centered, Behavioral Obesity Intervention for Latino-American Preschool-aged ChildrenPediatrics201213044545610.1542/peds.2011-3762<?supplied-pmid 22869834?>22869834 </plain></SENT>
</text></ref><ref id="CR38"><text><SENT sid="203" pm="."><plain>38.RobinsonTNMathesonDMKraemerHCWilsonDMObarzanekEThompsonNSA Randomized Controlled Trial of Culturally Tailored Dance and Reducing Screen Time to Prevent Weight Gain in Low-Income African American Girls: Stanford GEMSArch Pediatr Adolesc Med2010164995100410.1001/archpediatrics.2010.197<?supplied-pmid 21041592?>21041592 </plain></SENT>
</text></ref><ref id="CR39"><text><SENT sid="204" pm="."><plain>39.NunesAPOliveiraIOSantosBRMillechCSilvaLPGonzalezDAQuality of DNA extracted from saliva samples collected with the Oragene DNA self-collection kitBMC Med Res Methodol2012126510.1186/1471-2288-12-65<?supplied-pmid 22559914?>22559914 </plain></SENT>
</text></ref><ref id="CR40"><text><SENT sid="205" pm="."><plain>40.NgDPKohDChooSChiaKSSaliva as a viable alternative source of human genomic DNA in genetic epidemiologyClin Chim Acta2006367818510.1016/j.cca.2005.11.024<?supplied-pmid 16388788?>16388788 </plain></SENT>
</text></ref><ref id="CR41"><text><SENT sid="206" pm="."><plain>41.ComuzzieAGColeSALastonSLVorugantiVSHaackKGibbsRANovel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic populationPLoS One20127e5195410.1371/journal.pone.0051954<?supplied-pmid 23251661?>23251661 </plain></SENT>
</text></ref><ref id="CR42"><text><SENT sid="207" pm="."><plain>42.Illumina Inc. </plain></SENT>
<SENT sid="208" pm="."><plain>Infinium HumanMethylation450 BeadChip Kit. </plain></SENT>
<SENT sid="209" pm="."><plain>2015 </plain></SENT>
</text></ref><ref id="CR43"><text><SENT sid="210" pm="."><plain>43.SandovalJHeynHMoranSSerra-MusachJPujanaMABibikovaMValidation of a DNA methylation microarray for 450,000 CpG sites in the human genomeEpigenetics2011669270210.4161/epi.6.6.16196<?supplied-pmid 21593595?>21593595 </plain></SENT>
</text></ref><ref id="CR44"><text><SENT sid="211" pm="."><plain>44.BibikovaMFanJBGoldenGate assay for DNA methylation profilingMethods Mol Biol200950714916310.1007/978-1-59745-522-0_12<?supplied-pmid 18987813?>18987813 </plain></SENT>
</text></ref><ref id="CR45"><text><SENT sid="212" pm="."><plain>45.DedeurwaerderSDefranceMBizetMCalonneEBontempiGFuksFA comprehensive overview of Infinium HumanMethylation450 data processingBrief Bioinform20141592994110.1093/bib/bbt054<?supplied-pmid 23990268?>23990268 </plain></SENT>
</text></ref><ref id="CR46"><text><SENT sid="213" pm="."><plain>46.ChenYALemireMChoufaniSButcherDTGrafodatskayaDZankeBWDiscovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarrayEpigenetics2013820320910.4161/epi.23470<?supplied-pmid 23314698?>23314698 </plain></SENT>
</text></ref><ref id="CR47"><text><SENT sid="214" pm="."><plain>47.ZouHHastieTRegularization and variable selection via the elastic netJ Roy Stat Soc B20056776810.1111/j.1467-9868.2005.00527.x </plain></SENT>
</text></ref><ref id="CR48"><text><SENT sid="215" pm="."><plain>48.AnjumSFourkalaEOZikanMWongAGentry-MaharajAJonesAA BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survivalGenome Med201464710.1186/gm567<?supplied-pmid 25067956?>25067956 </plain></SENT>
</text></ref><ref id="CR49"><text><SENT sid="216" pm="."><plain>49.SchmutzMZucknickMSchlenkRFDöhnerKDöhnerHPlassCDifferential DNA Methylation Predicts Response To Combined Treatment Regimens With a DNA Methyltransferase Inhibitor In Acute Myeloid Leukemia (AML)Blood2013122253910.1182/blood-2013-06-50794723886836 </plain></SENT>
</text></ref><ref id="CR50"><text><SENT sid="217" pm="."><plain>50.Wilhelm-BenartziCSKoestlerDCKaragasMRFlanaganJMChristensenBCKelseyKTReview of processing and analysis methods for DNA methylation array dataBr J Cancer20131091394140210.1038/bjc.2013.496<?supplied-pmid 23982603?>23982603 </plain></SENT>
</text></ref><ref id="CR51"><text><SENT sid="218" pm="."><plain>51.HorvathSDNA methylation age of human tissues and cell typesGenome Biol201314R11510.1186/gb-2013-14-10-r115<?supplied-pmid 24138928?>24138928 </plain></SENT>
</text></ref><ref id="CR52"><text><SENT sid="219" pm="."><plain>52.HochbergYA sharper Bonferroni procedure for multiple tests of significanceBiometricka.19887580080210.1093/biomet/75.4.800 </plain></SENT>
</text></ref><ref id="CR53"><text><SENT sid="220" pm="."><plain>53.ZhuSHeymsfieldSBToyoshimaHWangZPietrobelliAHeshkaSRace-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factorsAm J Clin Nutr200581409415<?supplied-pmid 15699228?>15699228 </plain></SENT>
</text></ref><ref id="CR54"><text><SENT sid="221" pm="."><plain>54.Colin BellAAdairLSPopkinBMEthnic differences in the association between body mass index and hypertensionAm J Epidemiol200215534635310.1093/aje/155.4.346<?supplied-pmid 11836199?>11836199 </plain></SENT>
</text></ref><ref id="CR55"><text><SENT sid="222" pm="."><plain>55.MisraAWasirJSVikramNKWaist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groupsNutrition20052196997610.1016/j.nut.2005.01.007<?supplied-pmid 15993041?>15993041 </plain></SENT>
</text></ref><ref id="CR56"><text><SENT sid="223" pm="."><plain>56.KramerAGreenJPollardJJrTugendreichSCausal analysis approaches in Ingenuity Pathway AnalysisBioinformatics20143052353010.1093/bioinformatics/btt703<?supplied-pmid 24336805?>24336805 </plain></SENT>
</text></ref><ref id="CR57"><text><SENT sid="224" pm="."><plain>57.JoHSchieveLASharmaAJHinkleSNLiRLindJNMaternal prepregnancy body mass index and child psychosocial development at 6 years of agePediatrics2015135e1198120910.1542/peds.2014-3058<?supplied-pmid 25917989?>25917989 </plain></SENT>
</text></ref><ref id="CR58"><text><SENT sid="225" pm="."><plain>58.ManuPDimaLShulmanMVancampfortDDe HertMCorrellCUWeight gain and obesity in schizophrenia: epidemiology, pathobiology, and managementActa Psychiatr Scand20151329710810.1111/acps.12445<?supplied-pmid 26016380?>26016380 </plain></SENT>
</text></ref><ref id="CR59"><text><SENT sid="226" pm="."><plain>59.ElshorbagyAKKozichVSmithADRefsumHCysteine and obesity: consistency of the evidence across epidemiologic, animal and cellular studiesCurr Opin Clin Nutr Metab Care201215495710.1097/MCO.0b013e32834d199f<?supplied-pmid 22108094?>22108094 </plain></SENT>
</text></ref><ref id="CR60"><text><SENT sid="227" pm="."><plain>60.ElshorbagyAKValdivia-GarciaMRefsumHButteNThe association of cysteine with obesity, inflammatory cytokines and insulin resistance in Hispanic children and adolescentsPLoS One20127e4416610.1371/journal.pone.0044166<?supplied-pmid 22984471?>22984471 </plain></SENT>
</text></ref><ref id="CR61"><text><SENT sid="228" pm="."><plain>61.VayaARiveraLHernandez-MijaresAde la FuenteMSolaERomagnoliMHomocysteine levels in morbidly obese patients: its association with waist circumference and insulin resistanceClin Hemorheol Microcirc2012524956<?supplied-pmid 22460264?>22460264 </plain></SENT>
</text></ref><ref id="CR62"><text><SENT sid="229" pm="."><plain>62.PlaisanceEPGreenwayFLBoudreauAHillKLJohnsonWDKrajcikRADietary methionine restriction increases fat oxidation in obese adults with metabolic syndromeJ Clin Endocrinol Metab201196E83684010.1210/jc.2010-2493<?supplied-pmid 21346062?>21346062 </plain></SENT>
</text></ref><ref id="CR63"><text><SENT sid="230" pm="."><plain>63.YoshinoJKleinSA novel link between circadian clocks and adipose tissue energy metabolismDiabetes2013622175217710.2337/db13-0457<?supplied-pmid 23801717?>23801717 </plain></SENT>
</text></ref><ref id="CR64"><text><SENT sid="231" pm="."><plain>64.SourenNYTierlingSFrynsJPDeromCWalterJZeegersMPDNA methylation variability at growth-related imprints does not contribute to overweight in monozygotic twins discordant for BMIObesity (Silver Spring)2011191519152210.1038/oby.2010.35321273997 </plain></SENT>
</text></ref><ref id="CR65"><text><SENT sid="232" pm="."><plain>65.WuYZhouSSmasCMDownregulated expression of the secreted glycoprotein follistatin-like 1 (Fstl1) is a robust hallmark of preadipocyte to adipocyte conversionMech Dev201012718320210.1016/j.mod.2009.12.003<?supplied-pmid 20043993?>20043993 </plain></SENT>
</text></ref><ref id="CR66"><text><SENT sid="233" pm="."><plain>66.FanNSunHWangYZhangLXiaZPengLFollistatin-like 1: a potential mediator of inflammation in obesityMediators Inflamm2013201375251910.1155/2013/752519<?supplied-pmid 24347831?>24347831 </plain></SENT>
</text></ref><ref id="CR67"><text><SENT sid="234" pm="."><plain>67.SchmidtVWillnowTEProtein sorting gone wrong - VPS10P domain receptors in cardiovascular and metabolic diseasesAtherosclerosis201624519419910.1016/j.atherosclerosis.2015.11.027<?supplied-pmid 26724530?>26724530 </plain></SENT>
</text></ref><ref id="CR68"><text><SENT sid="235" pm="."><plain>68.GoodarziMOLehmanDMTaylorKDGuoXCuiJQuinonesMJSORCS1: a novel human type 2 diabetes susceptibility gene suggested by the mouseDiabetes2007561922192910.2337/db06-1677<?supplied-pmid 17426289?>17426289 </plain></SENT>
</text></ref><ref id="CR69"><text><SENT sid="236" pm="."><plain>69.PatersonADWaggottDBorightAPHosseiniSMShenESylvestreMPA genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucoseDiabetes20105953954910.2337/db09-0653<?supplied-pmid 19875614?>19875614 </plain></SENT>
</text></ref><ref id="CR70"><text><SENT sid="237" pm="."><plain>70.GranhallCParkHBFakhrai-RadHLuthmanHHigh-resolution quantitative trait locus analysis reveals multiple diabetes susceptibility loci mapped to intervals &lt; 800 kb in the species-conserved Niddm1i of the GK ratGenetics20061741565157210.1534/genetics.106.062208<?supplied-pmid 16951059?>16951059 </plain></SENT>
</text></ref><ref id="CR71"><text><SENT sid="238" pm="."><plain>71.DonohoeGMorrisDWCorvinAThe psychosis susceptibility gene ZNF804A: associations, functions, and phenotypesSchizophr Bull20103690490910.1093/schbul/sbq080<?supplied-pmid 20688871?>20688871 </plain></SENT>
</text></ref><ref id="CR72"><text><SENT sid="239" pm="."><plain>72.GirgentiMJLoTurcoJJMaherBJZNF804a regulates expression of the schizophrenia-associated genes PRSS16, COMT, PDE4B, and DRD2PLoS One20127e3240410.1371/journal.pone.0032404<?supplied-pmid 22384243?>22384243 </plain></SENT>
</text></ref><ref id="CR73"><text><SENT sid="240" pm="."><plain>73.BalogZKissIKeriSZNF804A may be associated with executive control of attentionGenes Brain Behav20111022322710.1111/j.1601-183X.2010.00657.x<?supplied-pmid 21040459?>21040459 </plain></SENT>
</text></ref><ref id="CR74"><text><SENT sid="241" pm="."><plain>74.DonohoeGRoseEFrodlTMorrisDSpoletiniIAdrianoFZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophreniaNeuroimage2011542132213710.1016/j.neuroimage.2010.09.089<?supplied-pmid 20934520?>20934520 </plain></SENT>
</text></ref><ref id="CR75"><text><SENT sid="242" pm="."><plain>75.LenczTSzeszkoPRDeRossePBurdickKEBrometEJBilderRMA schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypesNeuropsychopharmacology2010352284229110.1038/npp.2010.102<?supplied-pmid 20664580?>20664580 </plain></SENT>
</text></ref><ref id="CR76"><text><SENT sid="243" pm="."><plain>76.BerkelSMarshallCRWeissBHoweJRoethRMoogUMutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardationNat Genet20104248949110.1038/ng.589<?supplied-pmid 20473310?>20473310 </plain></SENT>
</text></ref><ref id="CR77"><text><SENT sid="244" pm="."><plain>77.BerkelSTangWTrevinoMVogtMObenhausHAGassPInherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiologyHum Mol Genet20122134435710.1093/hmg/ddr470<?supplied-pmid 21994763?>21994763 </plain></SENT>
</text></ref><ref id="CR78"><text><SENT sid="245" pm="."><plain>78.KumarRASHANK2 redemption: another synaptic protein for mental retardation and autismClin Genet20107851952110.1111/j.1399-0004.2010.01530_2.x<?supplied-pmid 20880122?>20880122 </plain></SENT>
</text></ref><ref id="CR79"><text><SENT sid="246" pm="."><plain>79.WonHLeeHRGeeHYMahWKimJILeeJAutistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor functionNature201248626126510.1038/nature11208<?supplied-pmid 22699620?>22699620 </plain></SENT>
</text></ref><ref id="CR80"><text><SENT sid="247" pm="."><plain>80.LeblondCSHeinrichJDelormeRProepperCBetancurCHuguetGGenetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disordersPLoS Genet20128e100252110.1371/journal.pgen.1002521<?supplied-pmid 22346768?>22346768 </plain></SENT>
</text></ref><ref id="CR81"><text><SENT sid="248" pm="."><plain>81.TseMTNeurodevelopmental disorders: exploring the links between SHANK2 and autismNat Rev Drug Discov20121151810.1038/nrd3780<?supplied-pmid 22722533?>22722533 </plain></SENT>
</text></ref><ref id="CR82"><text><SENT sid="249" pm="."><plain>82.LiuYNiuNZhuXDuTWangXChenDGenetic variation and association analyses of the nuclear respiratory factor 1 (nRF1) gene in Chinese patients with type 2 diabetesDiabetes20085777778210.2337/db07-0008<?supplied-pmid 18071027?>18071027 </plain></SENT>
</text></ref><ref id="CR83"><text><SENT sid="250" pm="."><plain>83.QuLHeBPanYXuYZhuCTangZAssociation between polymorphisms in RAPGEF1, TP53, NRF1 and type 2 diabetes in Chinese Han populationDiabetes Res Clin Pract20119117117610.1016/j.diabres.2010.11.019<?supplied-pmid 21146886?>21146886 </plain></SENT>
</text></ref><ref id="CR84"><text><SENT sid="251" pm="."><plain>84.van TienenFHLindseyPJvan der KallenCJSmeetsHJProlonged Nrf1 overexpression triggers adipocyte inflammation and insulin resistanceJ Cell Biochem20101111575158510.1002/jcb.22889<?supplied-pmid 21053274?>21053274 </plain></SENT>
</text></ref><ref id="CR85"><text><SENT sid="252" pm="."><plain>85.PattiMEButteAJCrunkhornSCusiKBerriaRKashyapSCoordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1Proc Natl Acad Sci U S A20031008466847110.1073/pnas.1032913100<?supplied-pmid 12832613?>12832613 </plain></SENT>
</text></ref><ref id="CR86"><text><SENT sid="253" pm="."><plain>86.McGovernDPGardetATorkvistLGoyettePEssersJTaylorKDGenome-wide association identifies multiple ulcerative colitis susceptibility lociNat Genet20104233233710.1038/ng.549<?supplied-pmid 20228799?>20228799 </plain></SENT>
</text></ref><ref id="CR87"><text><SENT sid="254" pm="."><plain>87.SabinMAWertherGAKiessWGenetics of obesity and overgrowth syndromesBest Pract Res Clin Endocrinol Metab20112520722010.1016/j.beem.2010.09.010<?supplied-pmid 21396586?>21396586 </plain></SENT>
</text></ref><ref id="CR88"><text><SENT sid="255" pm="."><plain>88.IgnoulSEggermontJCBS domains: structure, function, and pathology in human proteinsAm J Physiol Cell Physiol2005289C1369137810.1152/ajpcell.00282.2005<?supplied-pmid 16275737?>16275737 </plain></SENT>
</text></ref><ref id="CR89"><text><SENT sid="256" pm="."><plain>89.Picker JD, Levy HL. </plain></SENT>
<SENT sid="257" pm="."><plain>Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency. </plain></SENT>
<SENT sid="258" pm="."><plain>In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. </plain></SENT>
<SENT sid="259" pm="."><plain>GeneReviews(R). </plain></SENT>
<SENT sid="260" pm="."><plain>Seattle (WA) 1993. </plain></SENT>
</text></ref><ref id="CR90"><text><SENT sid="261" pm="."><plain>90.LiaoYCLoSHDeleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liverInt J Biochem Cell Biol20084084384710.1016/j.biocel.2007.04.008<?supplied-pmid 17521951?>17521951 </plain></SENT>
</text></ref><ref id="CR91"><text><SENT sid="262" pm="."><plain>91.XueWKrasnitzALucitoRSordellaRVanaelstLCordon-CardoCDLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinomaGenes Dev2008221439144410.1101/gad.1672608<?supplied-pmid 18519636?>18519636 </plain></SENT>
</text></ref><ref id="CR92"><text><SENT sid="263" pm="."><plain>92.WongCCWongCMKoFCChanLKChingYPYamJWDeleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinomaPLoS One20083e277910.1371/journal.pone.0002779<?supplied-pmid 18648664?>18648664 </plain></SENT>
</text></ref><ref id="CR93"><text><SENT sid="264" pm="."><plain>93.WongCMYamJWChingYPYauTOLeungTHJinDYRho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinomaCancer Res2005658861886810.1158/0008-5472.CAN-05-1318<?supplied-pmid 16204057?>16204057 </plain></SENT>
</text></ref><ref id="CR94"><text><SENT sid="265" pm="."><plain>94.TripathiVPopescuNCZimonjicDBDLC1 interaction with alpha-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activityMol Cell Biol2012322145215910.1128/MCB.06580-11<?supplied-pmid 22473989?>22473989 </plain></SENT>
</text></ref><ref id="CR95"><text><SENT sid="266" pm="."><plain>95.GongEYParkELeeHJLeeKExpression of Atp8b3 in murine testis and its characterization as a testis specific P-type ATPaseReproduction200913734535110.1530/REP-08-0048<?supplied-pmid 19017724?>19017724 </plain></SENT>
</text></ref><ref id="CR96"><text><SENT sid="267" pm="."><plain>96.FolmerDEElferinkRPPaulusmaCCP4 ATPases - lipid flippases and their role in diseaseBiochim Biophys Acta2009179162863510.1016/j.bbalip.2009.02.008<?supplied-pmid 19254779?>19254779 </plain></SENT>
</text></ref><ref id="CR97"><text><SENT sid="268" pm="."><plain>97.HarrisMJAriasIMFIC1, a P-type ATPase linked to cholestatic liver disease, has homologues (ATP8B2 and ATP8B3) expressed throughout the bodyBiochim Biophys Acta2003163312713110.1016/S1388-1981(03)00107-0<?supplied-pmid 12880872?>12880872 </plain></SENT>
</text></ref><ref id="CR98"><text><SENT sid="269" pm="."><plain>98.ChengIKChingAKChanTCChanAWWongCKChoyKWReduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosisJ Pathol2010220348360<?supplied-pmid 19927314?>19927314 </plain></SENT>
</text></ref><ref id="CR99"><text><SENT sid="270" pm="."><plain>99.ChenCFYehSHChenDSChenPJJouYSMolecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11Genes Chromosomes Cancer20054432032810.1002/gcc.20247<?supplied-pmid 16075462?>16075462 </plain></SENT>
</text></ref><ref id="CR100"><text><SENT sid="271" pm="."><plain>100.ParkKSShinHDParkBLCheongHSChoYMLeeHKPutative association of peroxisome proliferator-activated receptor gamma co-activator 1beta (PPARGC1B) polymorphism with Type 2 diabetes mellitusDiabet Med20062363564210.1111/j.1464-5491.2006.01882.x<?supplied-pmid 16759305?>16759305 </plain></SENT>
</text></ref><ref id="CR101"><text><SENT sid="272" pm="."><plain>101.AndersenGWegnerLYanagisawaKRoseCSLinJGlumerCEvidence of an association between genetic variation of the coactivator PGC-1beta and obesityJ Med Genet20054240240710.1136/jmg.2004.026278<?supplied-pmid 15863669?>15863669 </plain></SENT>
</text></ref><ref id="CR102"><text><SENT sid="273" pm="."><plain>102.QueirozEMCandidoAPCastroIMBastosAQMachado-CoelhoGLFreitasRNIGF2, LEPR, POMC, PPARG, and PPARGC1 gene variants are associated with obesity-related risk phenotypes in Brazilian children and adolescentsBraz J Med Biol Res20154859560210.1590/1414-431X20154155<?supplied-pmid 25923461?>25923461 </plain></SENT>
</text></ref><ref id="CR103"><text><SENT sid="274" pm="."><plain>103.Psychiatric GWAS Consortium Bipolar Disorder Working Group. </plain></SENT>
<SENT sid="275" pm="."><plain>Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. </plain></SENT>
<SENT sid="276" pm="."><plain>Nat Genet. </plain></SENT>
<SENT sid="277" pm="."><plain>2011;43:977–83. </plain></SENT>
</text></ref><ref id="CR104"><text><SENT sid="278" pm="."><plain>104.HeinrichALourdusamyATzschoppeJVollstadt-KleinSBuhlerMSteinerSThe risk variant in ODZ4 for bipolar disorder impacts on amygdala activation during reward processingBipolar Disord20131544044510.1111/bdi.12068<?supplied-pmid 23611537?>23611537 </plain></SENT>
</text></ref><ref id="CR105"><text><SENT sid="279" pm="."><plain>105.CraddockNSklarPGenetics of bipolar disorderLancet20133811654166210.1016/S0140-6736(13)60855-7<?supplied-pmid 23663951?>23663951 </plain></SENT>
</text></ref><ref id="CR106"><text><SENT sid="280" pm="."><plain>106.SulimanSGStanikJMcCullochLJWilsonNEdghillELMisovicovaNSevere insulin resistance and intrauterine growth deficiency associated with haploinsufficiency for INSR and CHN2: new insights into synergistic pathways involved in growth and metabolismDiabetes2009582954296110.2337/db09-0787<?supplied-pmid 19720790?>19720790 </plain></SENT>
</text></ref><ref id="CR107"><text><SENT sid="281" pm="."><plain>107.MaedaSArakiSBabazonoTToyodaMUmezonoTKawaiKReplication study for the association between four Loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetesDiabetes2010592075207910.2337/db10-0067<?supplied-pmid 20460425?>20460425 </plain></SENT>
</text></ref><ref id="CR108"><text><SENT sid="282" pm="."><plain>108.HuCZhangRYuWWangJWangCPangCCPVL/CHN2 genetic variant is associated with diabetic retinopathy in Chinese type 2 diabetic patientsDiabetes2011603085308910.2337/db11-0028<?supplied-pmid 21911749?>21911749 </plain></SENT>
</text></ref><ref id="CR109"><text><SENT sid="283" pm="."><plain>109.Gamboa-MelendezMAHuerta-ChagoyaAMoreno-MaciasHVazquez-CardenasPOrdonez-SanchezMLRodriguez-GuillenRContribution of common genetic variation to the risk of type 2 diabetes in the Mexican Mestizo populationDiabetes2012613314332110.2337/db11-0550<?supplied-pmid 22923468?>22923468 </plain></SENT>
</text></ref><ref id="CR110"><text><SENT sid="284" pm="."><plain>110.HayesMGPluzhnikovAMiyakeKSunYNgMCRoeCAIdentification of type 2 diabetes genes in Mexican Americans through genome-wide association studiesDiabetes2007563033304410.2337/db07-0482<?supplied-pmid 17846124?>17846124 </plain></SENT>
</text></ref><ref id="CR111"><text><SENT sid="285" pm="."><plain>111.TakataAIwayamaYFukuoYIkedaMOkochiTMaekawaMA population-specific uncommon variant in GRIN3A associated with schizophreniaBiol Psychiatry20137353253910.1016/j.biopsych.2012.10.024<?supplied-pmid 23237318?>23237318 </plain></SENT>
</text></ref><ref id="CR112"><text><SENT sid="286" pm="."><plain>112.ShenYCLiaoDLChenJYWangYCLaiICLiouYJExomic sequencing of the ionotropic glutamate receptor N-methyl-D-aspartate 3A gene (GRIN3A) reveals no association with schizophreniaSchizophr Res2009114253210.1016/j.schres.2009.07.005<?supplied-pmid 19665356?>19665356 </plain></SENT>
</text></ref><ref id="CR113"><text><SENT sid="287" pm="."><plain>113.DiekstraFPvan VughtPWvan RheenenWKoppersMPasterkampRJvan EsMAUNC13A is a modifier of survival in amyotrophic lateral sclerosisNeurobiol Aging20123363010.1016/j.neurobiolaging.2011.10.029<?supplied-pmid 22118904?>22118904 </plain></SENT>
</text></ref><ref id="CR114"><text><SENT sid="288" pm="."><plain>114.van EsMAVeldinkJHSarisCGBlauwHMvan VughtPWBirveAGenome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosisNat Genet2009411083108710.1038/ng.442<?supplied-pmid 19734901?>19734901 </plain></SENT>
</text></ref><ref id="CR115"><text><SENT sid="289" pm="."><plain>115.DaoudHBelzilVDesjarlaisACamuWDionPARouleauGAAnalysis of the UNC13A gene as a risk factor for sporadic amyotrophic lateral sclerosisArch Neurol20106751651710.1001/archneurol.2010.46<?supplied-pmid 20385924?>20385924 </plain></SENT>
</text></ref><ref id="CR116"><text><SENT sid="290" pm="."><plain>116.KoppersMGroenEJVan VughtPWVan RheenenWWitteveenEVan EsMAScreening for rare variants in the coding region of ALS-associated genes at 9p21.2 and 19p13.3Neurobiol Aging2013341518 e5710.1016/j.neurobiolaging.2012.09.018 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
